Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News

Related or similar articles

June 13, 2024

Advancing Science at Labshares: Diagonal Therapeutics' Journey

Labshares News
October 2, 2025

Why Labshares is Thriving in a Tough Environment

Blog Posts
May 12, 2025

Leasing / Subleasing vs. Shared Labs: Why Labshares is the Capital-Efficient Choice for Biotechs

Blog Posts